Unmasking the Mind-Organic Psychiatric Manifestations in Long-term Multiple Sclerosis:
A Case Series
Sukriti Pruthi1*, Surender Sharma2, Amandeep Singh Dhaliwal1, Nandish M1 and Rushdhan Husnee Ageel1
1Junior Resident, Department of Psychiatry, Armed Forces Medical College, Pune, India
2Associate Professor, Department of Psychiatry, Command Hospital Southern Command, Pune, India
*Corresponding Author: Sukriti Pruthi, Junior Resident, Department of Psychiatry, Armed Forces Medical College, Pune, India.
Received:
October 21, 2025; Published: November 11, 2025
Abstract
Multiple sclerosis (MS) is a chronic demyelinating disorder often accompanied by neuropsychiatric manifestations arising from fronto-limbic and prefrontal involvement. This case series describes four patients with long-standing MS who developed organic psychiatric syndromes independent of neurological relapse. Two patients presented with organic depressive disorder, one with organic anxiety disorder, and organic personality disorder. The MRI Brain scans of the cases revealed fronto-cingulate, orbitofrontal, or limbic demyelination, corresponding with the clinical features. They improved significantly with SSRI’s, mood stabilizers, and psychotherapy. The findings highlight that psychiatric symptoms in chronic MS often reflect direct neurobiological consequences of demyelination rather than reactive psychological distress, emphasizing the importance of integrated neuropsychiatric assessment in MS management for aiding better functional and holistic outcomes.
Keywords: Multiple Sclerosis; Organic Depressive Disorder; Organic Anxiety Disorder; Organic Personality Disorder
References
- Feinstein A. “The clinical neuropsychiatry of multiple sclerosis”. Cambridge University Press (2007).
- Marrie RA., et al. “Differences in the burden of psychiatric comorbidity in MS vs the general population”. Neurology22 (2015): 1972-1979.
- Masuccio FG., et al. “Imaging and depression in multiple sclerosis: a historical perspective”. Neurological Sciences 3 (2021): 835-845.
- Feinstein A., et al. “Structural brain abnormalities in multiple sclerosis patients with major depression”. Neurology 4 (2004): 586-590.
- Rao SM. “Cognitive dysfunction in multiple sclerosis. Multiple sclerosis and related disorders: Clinical guide to diagnosis, medical management, and rehabilitation”. (2019): 191-198.
- Chiaravalloti ND and DeLuca J. “Cognitive impairment in multiple sclerosis”. The Lancet Neurology12 (2008): 1139-1151.
- Feinstein A., et al. “The link between multiple sclerosis and depression”. Nature Reviews Neurology9 (2014): 507-517.
- Benedict RH and Zivadinov R. “Risk factors for and management of cognitive dysfunction in multiple sclerosis”. Nature Reviews Neurology6 (2011): 332-342.
- Korostil M and Feinstein A. “Anxiety disorders and their clinical correlates in multiple sclerosis patients”. Multiple Sclerosis Journal1 (2007): 67-72.
- Ellwardt E., et al. “Network alterations underlying anxiety symptoms in early multiple sclerosis”. Journal of Neuroinflammation1 (2022): 119.
- Hillyer A., et al. “Association between limbic system lesions and anxiety in persons with multiple sclerosis”. Multiple Sclerosis and Related Disorders 79 (2023): 105021.
- Stathopoulou A., et al. “Personality characteristics and disorders in multiple sclerosis patients: assessment and treatment”. International Review of Psychiatry1 (2010): 43-54.
- Gioia MC., et al. “Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: An fMRI study”. Brain and Cognition3 (2009): 320-7.
- Feinstein A., et al. “Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study”. Journal of Neurology, Neurosurgery and Psychiatry 10 (1992): 869-876.
- Pérez LP., et al. “Treatment of mood disorders in multiple sclerosis”. Current Treatment Options in Neurology1 (2015): 323.
- Marrie RA. “Comorbidity in multiple sclerosis: implications for patient care”. Nature Reviews Neurology 6 (2017): 375-382.
Citation
Copyright